Skip to Main Content

Paper Details

Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias.
Nat Immunol
11
2021
Author NameAffiliation
Michael S CuocoBroad Institute of Harvard and MIT
Steven A CarrBroad Institute of MIT and Harvard
Steven A CarrBroad Institute of MIT and Harvard
Sushrut S WaikarBrigham and Women's Hospital, Harvard Medical School
Sushrut S WaikarBoston University Medical Center
Joseph V BonventreBrigham and Women's Hospital, Harvard Medical School
Jerome RitzDana-Farber Cancer Institute, Harvard Medical School
Richard M StoneDana-Farber Cancer Institute, Harvard Medical School
David P SteensmaDana-Farber Cancer Institute, Harvard Medical School
Aviv RegevBroad Institute of Harvard and MIT
Aviv RegevHoward Hughes Medical Institute
Aviv RegevKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Aviv RegevBroad Institute of Harvard and MIT
Aviv RegevHoward Hughes Medical Institute
Aviv RegevKoch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • 1 - 15

Datasets

Release 1.2